Early propranolol treatment of infantile hemangiomas improves outcome

Giachetti, Ana; Díaz, María Sol; Boggio, Paula; Posadas Martínez, María Lourdes.
An. bras. dermatol ; 98(3): 310-315, May-June 2023. tab, graf
Artículo en Inglés | LILACS-Express | ID: biblio-1439216

Documentos relacionados

  1. Early propranolol treatment of infantile hemangiomas improves outcome.
  2. Our experience with propranolol for infantile hemangioma.
  3. Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate.
  4. Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study.
  5. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth.
  6. Knowledge of community pharmacists on infantile haemangioma: Gaps and lack confidence to deliver propranolol still need to be filled.
  7. Topical Formulations of Propranolol for Infantile Hemangiomas: Characteristics of Formulations and Three Cases of Infants Administered Topical Propranolol Cream.
  8. Management of infantile hemangiomas-experience of a tertiary hospital.
  9. Segmental facial infantile haemangiomas in the era of propranolol: evaluation at 6 years of age.
  10. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.